Angion Biomedica Corp
ANGN
NGS
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
1.03
USD
0.00
(0.00%)
Optionable: No Market Cap: 31 M 90-day average vol: 169,703
Previous close: 1.03 Open: 1.06 Bid: 1.11 Ask: 1.11
52 week range
0.98 13.66
Last updated: Friday 12th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Chart
News
Angion Announces Participation in Upcoming Investment Conferences
Yahoo Finance 2/28/2022
Angion Biomedica: Selling At Cash Value
Seeking Alpha 2/7/2022
Angion Biomedica (ANGN) Investor Presentation - Slideshow
Seeking Alpha 1/11/2022
Trade Alert: The President Of Angion Biomedica Corp. (NASDAQ:ANGN), Jay Venkatesan, Has Just Spent US$730k Buying 24% More Shares
Yahoo Finance 1/5/2022
Angion Provides Corporate Update and Announces Participation in Upcoming Investor Conference
Yahoo Finance 1/4/2022
Angion (ANGN) Kidney Drug Misses Third Study Goal in 2021
Yahoo Finance 12/13/2021
Angion's ANG-3777 Faces Third Failure In 2021, This Time Flunks Acute Kidney Injury Trial
Yahoo Finance 12/10/2021
Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury
Yahoo Finance 12/10/2021
Angion down 17% after mid-stage acute kidney injury drug misses primary endpoint
Seeking Alpha 12/9/2021
Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surgery-Associated Acute Kidney Injury
Yahoo Finance 12/9/2021
Angion Biomedica EPS beats by $0.19, beats on revenue
Seeking Alpha 11/12/2021
Angion Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Yahoo Finance 11/12/2021
Angion Presents Multiple Posters on ANG-3070 at Kidney Week 2021, Including Preclinical Data and Design of Upcoming Phase 2 Study
Yahoo Finance 11/5/2021
Angion to Participate in Upcoming Investment Conference
Yahoo Finance 11/2/2021
Why Did Angion Biomedica's Shares tumble Premarket Today?
Yahoo Finance 10/27/2021
Angion shares drop 55% as kidney transplant drug misses endpoint in late-stage trial
Seeking Alpha 10/26/2021
Angion and Vifor Pharma Report Topline Results from Phase 3 Trial of ANG-3777 in Kidney Transplant Patients at Risk for Delayed Graft Function
Yahoo Finance 10/26/2021
10 Healthcare Stocks to Buy According to Peter S. Park’s Park West Asset Management
Yahoo Finance 10/21/2021
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!